Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464606 · ClinicalTrials.gov registry record · NA
International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
A NA study of Pleuropulmonary Blastoma, sponsored by Children's Hospitals and Clinics of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT01464606 is a NA study of Pleuropulmonary Blastoma that is active but no longer recruiting, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 156 participants, below the 1,670-participant average among 3 other Pleuropulmonary Blastoma trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01464606, a NA study of Pleuropulmonary Blastoma, is active but no longer recruiting, sponsored by Children's Hospitals and Clinics of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best" therapy. For many years, children with PPB around the world have been treated according to decisions made case-by-case in many different hospitals by many different physicians. No treatment has been tested in a large group of PPB patients. The goal is to treat many children with one treatment program and to learn the results of the treatment.
Conditions Studied
Interventions
- DRUG Cyclophosphamide
- DRUG Doxorubicin
- DRUG Vincristine
- DRUG Ifosfamide
- DRUG Dactinomycin
Study Locations (1)
Minnesota
- Anne K Harris - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2009-12-22 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01464606
The ClinicalTrials.gov registry entry for NCT01464606 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,670-participant average among 3 other Pleuropulmonary Blastoma trials with a reported enrollment target (91% lower). The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleuropulmonary Blastoma appearing as the primary indexed condition, and to 5 interventions - of which Cyclophosphamide is the first listed.
NCT01464606 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01464606 about?
NCT01464606 is a clinical study titled "International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry". Pleuropulmonary Blastoma (PPB) is very rare and there is no established "standard" or "best" therapy. For many years, children with PPB around the world have been treated according to decisions made case-by-case in many different hospitals by many different physicians. No treatment has been tested i...
What is the current status of trial NCT01464606?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 156 participants. The study started on 2009-12-22. Estimated completion is 2028-12.
What conditions does trial NCT01464606 study?
This clinical trial studies the following conditions: Pleuropulmonary Blastoma.
What interventions are being tested in trial NCT01464606?
The interventions under investigation include: Cyclophosphamide (DRUG), Doxorubicin (DRUG), Vincristine (DRUG), Ifosfamide (DRUG), Dactinomycin (DRUG).
Who is sponsoring clinical trial NCT01464606?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01464606 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pleuropulmonary Blastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
International PPB/DICER1 Registry
RECRUITING
-
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
RECRUITING · Phase 3
-
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.